Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

ChineseInvestors.com, Inc. (CIIX) Executes a First to Market Milestone

A population of over 1.2 billion people is one heck of a target market, especially when insulated by language. ChineseInvestors.com (OTCQB: CIIX) has leveraged this demographic to market a broad range of products, services and information specifically for the Chinese speaking population. The company provides real-time market commentary, analysis, and education-related services in the Chinese […]

Bollente Companies, Inc. (BOLC) is “One to Watch”

Bollente Companies, Inc. (OTCQB: BOLC) is in the early stages of developing a diverse portfolio of companies, targeting disruptive technologies that positively impact the environment and emerging economies. Their current focus is on high-efficiency electric tankless water heaters, manufactured and sold under “trutankless”, a division of Bollente, including a line of economy tankless water heaters […]

eXp World Holdings, Inc. (EXPI) Keeps Salespeople Satisfied and Selling

The sales profession is known for sales cycle stress, pressures to meet quotas and the debilitating psychological impact of constant rejection. Combined, these factors are known contributors to the sales industry’s exceptionally high turnover rates and lost productivity. The satisfaction level of salespeople may not seem to correlate directly with business objectives, but it substantially […]

India Globalization Capital, Inc. (NYSE: IGC) Aims to Become a Leading Provider of Cannabis-Based Combination Therapies

India Globalization Capital, Inc. (NYSE MKT: IGC) has set a long-term goal for itself in the U.S. of becoming a leading provider of cannabis-based pharmaceutical and nutraceutical products. This is a transition away from its earlier short-term strategy, including the sale of electronics and development of a hotel site in Malaysia. To this end, the […]

Moxian, Inc. (NASDAQ: MOXC) Sales Projected To Reach $62 Million in FY 2020 by SeeThruEquity Report

Moxian, Inc. (NASDAQ: MOXC) is poised to generate sales of greater than $62 million and a gross profit of more than $39 million in FY 2020, according to the SeeThruEquity research report on the company (http://nnw.fm/T6Aj4). Moxian is a China-based high-technology marketing company which has offered a beta no-charge platform in China’s large online-to-offline (O2O) […]

 

From Our Blog

Antisense’s Moment: How Rational Design Is Rewriting Drug Development Economics

December 15, 2025

The pharmaceutical industry has long faced sobering odds: about 90% of drug candidates fail before reaching market. For small molecules, approval rates hover at very low odds, often requiring up to two decades of development. In oncology, success rates fall to just 3%. These economics have created a bottleneck that leaves patients waiting years for […]

Rotate your device 90° to view site.